Chinese Journal of Hepatology 2008 Issue 2 du zhe zuo zhe bian zhe

..............page:100

The strategy of anti-virus treatment of hepatitis B virus infections in women during their reproductive age
CAI Hao-dong;LIU Min

..............page:159-160

Indoleamine-2,3-dioxygenase and the immune microenvironment of chronic hepatitis B patients
CHEN Yong-bing;LI Si-dan;GONG Jian-ping

..............page:157-158

Effect of regulatory T-lymphocytes on the pathogenesis and prognosis of liver diseases
XING Shao-jun;WANG Fu-sheng

..............page:155-156

The role of the immune system in viral hepatitis
YAN Wei-ming;ZOU Yong;NING Qin

..............page:152-154

Specific activities of SMP8 promotor in activating hepatic stellate cells
CHANG Ying;JIANG Hua-jun;SUN Xue-mei;AI Li;CHEN Ting;YUAN Shun-yu;SONG Yu-hu;LIN Ju-sheng

..............page:150-151

Expressions of stromal cell-derived factor-1 and of its receptor CXCR4 in rat proliferating hepatic oval cells
HUANG Xiao-ming;JIAO Xing-yuan;ZENG San-ping;DU Jun;HU Yi-ze;LUO Can-qiao

..............page:148-149

The relationship between T cell subsets and secondary bacterial infection and prognosis of patients with chronic severe hepatitis B
SUN Qing-feng;DAI Mei-yong;CHEN Wei;DING Ji-guang;NI Wu;XU Dao-zhen

..............page:146-147

A two-year animal experimental study on the pathological effects of Helicobacter pylori on liver tissues
TIAN Xue-fei;FAN Xue-gong;HUANG Xun;FU Chun-yan;DAI Hong;HUANG Yan

..............page:129-133

The effect of calorie restriction on the expression of liver's gluconeogenesis genes of rats fed a high fat diet
LUO Ming-juan;CHEN Lu-lu;ZHENG Juan;ZENG Tian-shu;DENG Xiu-ling

..............page:125-128

An in vitro model applicable for fatty liver lipotoxicity pharmacological research
HU Yi-yang;ZHANG Hui;CHEN Shao-dong;FENG Qin;LU Xiong;TANG Ying-zi

..............page:121-124

The etiology and management of postoperative hyperbilirubinemia after orthotopic liver transplantation
MA Yi;HE Xiao-shun;ZHU Xiao-feng;WANG Guo-dong;WANG Dong-ping;JU Wei-qiang;WU Lin-wei;HU An-bin;TAI Qiang

..............page:117-120

Evaluation of the risk of clonorchiasis inducing primary hepatocellular carcinoma
TAN Sheng-kui;QIU Xiao-qiang;YU Hong-ping;ZENG Xiao-yun;ZHAO Yin-nong;HU Lang

..............page:114-116

A quantitative analysis of mitochondrial protein differential expressions in hydroxycamptothecin-treated hepatoma cells
YAN Yu-rong;FU Yu-rong;QIU Zong-yin

..............page:109-113

The expression and significance of vascular endothelial growth factor and its receptors in hepatocellular carcinoma cell lines with various metastatic potentialities
AI Jun-hua;ZHENG Shu-guo;ZENG Yong-yi;XIONG Yan;ZHANG Lei-da;DONG Jia-hong

..............page:105-108

Establishment of an Ⅰ-SceI system and its application to introduce DNA double-strand break into human hepatoma cell line HepG2
REN Jing-hua;HE Wen-shan;LIN Ju-sheng;ZHANG Qiang;HE Xing-xing;CHEN Qiong;LIU Yao;XU Dong

..............page:101-104

Effects of CpG-ODN combined with HBsAg on the phenotype,function and the activity of NF-kappa B and AP-1 of monocyte-derived dendritic cells in chronic hepatitis B patients
XIANG Xiao-xing;ZHOU Xia-qiu;XIE Qing;YU Hong;ZHOU Hui-juan

..............page:97-100

Effect of silencing STAT3 gene with siRNA on HepG2 and SMMC-7721 hepatocarcinoma cell lines
GUO Jin-ying;WEN Yang-an;JIANG Xi-xin;LIU Jin-bo;ZHANG Yan-liang;TU Zhi-guang

..............page:144-145

Protective effect of heme oxygenase on hepatic ischemia reperfusion injury in rats
FENG Zhi-jie;CHEN Xiang-ping

..............page:142-143

Establishement of a model for predicting the prognosis in patients with liver cirrhosis
CHENG Yuan-qiao;WU Fu-quan;KUANG Ming-zi;LIU Jun;MO Xin-fa;WANG Wen-qi;SONGJia-wu;LIN Ju-sheng

..............page:140-141

Association of 54G/C single nucleotide polymorphism of sterol regulatory element-binding protein 1c with nonalcoholic fatty liver disease
ZHUANG Li-wei;XU Hui;LIU Ying

..............page:138-139

Images of primary hepatic angiosarcomas
ZHOU Mei-ling;YAN Fu-hua;YE Fang;XIONG Zhuang;WANG Jian-hua;JI Yuan

..............page:136-137

A model of end-stage liver disease for survival evaluation of patients with benign liver diseases after liver transplantation
ZHENG Wei-ping;SHEN Zhong-yang;ZHU Zhi-jun;ZHENG Hong;DENG Yong-lin;PAN Cheng;LIU Yi-he;SUN Li-ying

..............page:134-135

Characteristics of HBcAg(18-27) CTL epitopes of the main epidemic HBV strains in China
MA Shi-wu;LIANG Min-feng;YU Yue-cheng;WANG Zhan-hui;ZHOU Bin;HOU Jin-lin

..............page:93-96

Protein expression and function of gene 2 transregulated by hepatitis B virus pre-s1 protein and its cloning
WANG Dan-qiong;GUO Jiang;CHENG Jun;ZHANG Jian-kang;ZHAO Long-feng;HONG Yuan;ZHANG Li-ying

..............page:88-92

Genotyping 238 HBV strains usin type-specific primer PCR combined with type-specific nucleotide analysis
ZENG Ai-zhong;HUANG Ai-long;GUO Jin-jun;DENG Xiao-yan;LI Qing-ling;HUANG Wen-xiang

..............page:84-87

Anti-viral therapy and immune responses in livers of chronic hepatitis B patients
WANG Fu-sheng;CHEN Wei-wei

..............page:81-83